chr1-1048186-G-A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_198576.4(AGRN):​c.3926G>A​(p.Arg1309Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000244 in 1,569,432 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1309W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0013 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

AGRN
NM_198576.4 missense

Scores

16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.24
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007351905).
BP6
Variant 1-1048186-G-A is Benign according to our data. Variant chr1-1048186-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 474128.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00135 (205/152044) while in subpopulation AFR AF = 0.00478 (198/41462). AF 95% confidence interval is 0.00423. There are 1 homozygotes in GnomAd4. There are 98 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.3926G>A p.Arg1309Gln missense_variant Exon 23 of 36 ENST00000379370.7 NP_940978.2 O00468-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.3926G>A p.Arg1309Gln missense_variant Exon 23 of 36 1 NM_198576.4 ENSP00000368678.2 O00468-6
AGRNENST00000651234.1 linkc.3611G>A p.Arg1204Gln missense_variant Exon 22 of 38 ENSP00000499046.1 A0A494C1I6
AGRNENST00000652369.2 linkc.3611G>A p.Arg1204Gln missense_variant Exon 22 of 35 ENSP00000498543.1 A0A494C0G5
AGRNENST00000620552.4 linkc.3512G>A p.Arg1171Gln missense_variant Exon 23 of 39 5 ENSP00000484607.1 A0A087X208

Frequencies

GnomAD3 genomes
AF:
0.00135
AC:
205
AN:
151932
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00479
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.000374
AC:
65
AN:
174004
AF XY:
0.000316
show subpopulations
Gnomad AFR exome
AF:
0.00551
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000720
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000126
AC:
178
AN:
1417388
Hom.:
0
Cov.:
35
AF XY:
0.000108
AC XY:
76
AN XY:
702078
show subpopulations
African (AFR)
AF:
0.00397
AC:
129
AN:
32494
American (AMR)
AF:
0.000219
AC:
9
AN:
41188
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25454
East Asian (EAS)
AF:
0.0000805
AC:
3
AN:
37246
South Asian (SAS)
AF:
0.0000368
AC:
3
AN:
81502
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40964
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5606
European-Non Finnish (NFE)
AF:
0.0000165
AC:
18
AN:
1094082
Other (OTH)
AF:
0.000272
AC:
16
AN:
58852
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00135
AC:
205
AN:
152044
Hom.:
1
Cov.:
32
AF XY:
0.00132
AC XY:
98
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.00478
AC:
198
AN:
41462
American (AMR)
AF:
0.000262
AC:
4
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4806
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67946
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
9
18
26
35
44
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000259
Hom.:
0
Bravo
AF:
0.00149
ESP6500AA
AF:
0.00307
AC:
13
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000330
AC:
38
Asia WGS
AF:
0.000289
AC:
1
AN:
3476

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Dec 07, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Oct 29, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Congenital myasthenic syndrome 8 Benign:1
Oct 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
14
DANN
Benign
0.96
Eigen
Benign
-0.99
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.71
T;T
MetaRNN
Benign
0.0074
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.94
L;.
PhyloP100
1.2
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.0
N;.
REVEL
Benign
0.048
Sift
Benign
0.22
T;.
Sift4G
Benign
0.20
T;T
Vest4
0.14
MVP
0.73
MPC
0.14
ClinPred
0.0072
T
GERP RS
2.4
gMVP
0.31
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Loading publications...

Other links and lift over

dbSNP: rs199680125; hg19: chr1-983566; API